The role of modulatory calcineurin-interacting proteins in calcineurin signaling

Trends in Cardiovascular Medicine

Volumn 13, Issue 1, 2003, Pages 15-21

  Rothermel, Beverly A ^a,d   Vega, Rick B ^b   Williams, R Sanders ^c  

^a Department of Internal Medicine ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; MODULATORY CALCINEURIN INTERACTING PROTEIN; PHOSPHATASE; PROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG;

BRAIN; FEEDBACK SYSTEM; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HEART; HEART FAILURE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CHROMOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION;

ANIMALS; CALCINEURIN; CARDIOMYOPATHY, HYPERTROPHIC; GENE EXPRESSION REGULATION; HEART FAILURE, CONGESTIVE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUSCLE PROTEINS; SIGNAL TRANSDUCTION;

EID: 0037237668     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00188-3     Document Type: Review

References (39)

1. 2+ flux. Cell. 83:1995;463-472.
2. Casas C., Martinez S., Pritchard M.A.et al. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis. Mech Dev. 101:2001;289-292.
3. Chien K.R. Stress pathways and heart failure. Cell. 98:1999;555-558.
4. Chin E.R., Olson E.N., Richardson J.A.et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12:1998;2499-2509.
5. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J Biol Chem. 276:2001;2313-2316.
6. Crawford D.R., Leahy K.P., Abramova N.et al. Adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Arch Biochem Biophys. 342:1997;6-12.
7. de la Pompa J.L., Timmerman L.A., Takimoto H.et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 392:1998;182-186.
8. Ermak G., Morgan T.E., Davies K.J. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J Biol Chem. 276:2001;38,787-38,794.
9. Frey N., Richardson J.A., Olson E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci USA. 97:2000;14,632-14,637.
10. Fuentes J.J., Genesca L., Kingsbury T.J.et al. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet. 9:2000;1681-1690.
11. Fuentes J.J., Pritchard M.A., Estivill X. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics. 44:1997;358-361.
12. Gorlach J., Fox D.S., Cutler N.S.et al. Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans. EMBO J. 19:2000;3618-3629.
13. Graef I.A., Chen F., Crabtree G.R. NFAT signaling in vertebrate development. Curr Opin Genet Dev. 11:2001;505-512.
14. Hill J.A., Rothermel B.A., Yoo K.D.et al. Targeted inhibition of calcineurin in pressure-overload cardiac hypertropy. preservation of systolic function J Biol Chem. 277:2002;10,251-10,255.
15. Izumo S., Nadal-Ginard B., Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA. 85:1988;339-343.
16. Kashishian A., Howard M., Loh C.et al. AKAP79 inhibits calcineurin through a site distinct from the immunophilin-binding region. J Biol Chem. 273:1998;27,412-27,419.
17. Kingsbury T.J., Cunningham K.W. A conserved family of calcineurin regulators. Genes Dev. 14:2000;1595-1604.
18. Lai M.M., Burnett P.E., Wolosker H.et al. Cain, a novel physiologic protein inhibitor of calcineurin. J Biol Chem. 273:1998;18,325-18,331.
19. Leahy K.P., Davies K.J., Dull M.et al. Adapt78, a stress-inducible mRNA, is related to the glucose-regulated protein family of genes. Arch Biochem Biophys. 368:1999;67-74.
20. Lin X., Sikkink R.A., Rusnak F., Barber D.L. Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein. J Biol Chem. 274:1999;36,125-36,131.
21. MacLellan W.R. Advances in the molecular mechanisms of heart failure. Curr Opin Cardiol. 15:2000;128-135.
22. Miskin J.E., Abrams C.C., Goatley L.C., Dixon L.K. A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science. 281:1998;562-565.
23. Miyazaki T., Kanou Y., Murata Y.et al. Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem. 271:1996;14,567-14,571.
24. Molkentin J.D., Dorn G.W. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 63:2001;391-426.
25. Molkentin J.D., Lu J.R., Antos C.L.et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
26. Nicol R.L., Frey N., Olson E.N. From the sarcomere to the nucleus. role of genetics and signaling in structural heart disease Annu Rev Genom Hum Genet. 1:2000;179-223.
27. Olson E.N., Williams R.S. Calcineurin signaling and muscle remodeling. Cell. 101:2000;689-692.
28. Ranger A.M., Grusby M.J., Hodge M.R.et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 392:1998;186-190.
29. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family. regulation and function Annu Rev Immunol. 15:1997;707-747.
30. Rothermel B., Vega R.B., Yang J.et al. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem. 275:2000;8719-8725.
31. Rothermel B.A., McKinsey T.A., Vega R.B.et al. Myocyte-enriched calcineurin interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci USA. 98:2001;3328-3333.
32. Rusnak F., Mertz P. Calcineurin. form and function Physiol Rev. 80:2000;1483-1521.
33. Strippoli P., Lenzi L., Petrini M.et al. A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4. characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2) Genomics. 64:2000;252-263.
34. Sun L., Youn H.D., Loh C.et al. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity. 8:1998;703-711.
35. Vega R.B., Yang J., Rothermel B.A.et al. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem. 277:2002;30,401-30,407.
36. Wang X., Culotta V.C., Klee C.B. Superoxide dismutase protects calcineurin from inactivation. Nature. 383:1996;434-437.
37. Wang Y., De Keulenaer G.W., Weingerg E.O.et al. Direct biomechanical induction of the endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes. Am J Physiol Heart Circ Physiol. 283:2002;H533-H539.
38. 2+ release channel closure in rat heart. J Physiol (London). 500:1997;343-354.
39. Yang J., Rothermel B., Vega R.B.et al. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res. 87:2000;e61-e68.